Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Expanding Usage in the Treatment and Prevention of Surgical Site Infection Propels Povidone Iodine Market Forward, Potential to Lower the Risk of Endometritis in Women to Open up New Revenue Stream, Says TMR

This image opens in the lightbox

News provided by

Transparency Market Research

19 Jul, 2021, 12:30 GMT

Share this article

Share toX

Share this article

Share toX

- Povidone iodine, when compared to chlorhexidine wash and intranasal mupirocin ointment, has the ability to treat MRSA infections because of its fast and better bactericidal action.

- Povidone iodine manufacturers are diversifying their revenue streams by ramping up manufacturing of topical medication compositions for infection management and wound healing.

ALBANY, N.Y., July 19, 2021 /PRNewswire/ -- Different areas of a human's oropharyngeal and oral cavities are colonised by a range of viruses, protozoa, fungi, and bacteria. Povidone iodine is regarded as the most efficacious mouthwash, as per a research conducted on the impact of several mouthwashes on oral healthcare. The demand for efficacious oral healthcare solutions is increasing as a result of increased knowledge of oral health, thanks to both private and public initiatives. In addition to that, changes in consumer lifestyles, particularly in developing nations are also likely to support demand for povidone iodine. These factors are likely to propel global povidone iodine market forward in the years to come. It povidone Iodine is commonly used as an antiseptic for the skin, for instance as Betadine. It can also be used for vaginal health and eyes in less concentrated forms. Surgeons make use of it before surgery to sterilise the skin. The most commonly used 10% solution is for disinfecting skin, but it could also further diluted to up to 0.3 %. The surge in the demand for disinfectants and antiseptics for different hygiene applications in the public health sector is expected to drive the global povidone iodine market over the projection period, from 2020 to 2030.

The global povidone iodine market is expected to grow at a CAGR of 5% over analysis timeframe, from 2020 to 2030 and it is anticipated to reach a value of US$ 256.7 Bn through 2030. During the continuing COVID-19 epidemic, the notion of skin sterilisation becomes more and more important. As a result, betadine antiseptic solutions come with the potential to significantly reduce the concentration of microorganisms on the skin.

Strong expertise with attention to detail makes our market research reports stand apart. Request a sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11612

Key Findings of Market Report

  • Potential of PVP-I to Prevent Infection of Surgery Site to Offer Growth Opportunities

Decolonization of the nasals is a standard technique for controlling and preventing the spread of MRSA (methicillin-resistant staphylococcus aureus) infections. As a result, the gold standard for treating MRSA infections is chlorhexidine wash and intranasal mupirocin ointment. Nonetheless, povidone iodine (PVP-I) as a potential decolonizing agent for treating MRSA infection are supported by failure and resistance associated with these treatment methods. As a result, businesses in the global povidone iodine market are increasing their production capacities in order to improve PVP-I availability.

Because of the fast, better bactericidal activities of povidone iodine in comparison with chlorhexidine wash and intranasal ointment, it also hold immense promise for the treatment of MRSA infections. The usefulness of PVP-I to reduce the likelihood of surgery site (SSI's) infection in orthopaedic operations is increased by businesses in the povidone iodine industry.

We deliver what we promise; Get our premium research report on Povidone Iodine Market with In-depth research, accurate analysis at https://www.transparencymarketresearch.com/checkout.php?rep_id=11612&ltype=S

  • Expanding Usage in Gynecological Issues to Accentuate Demand for Povidone Iodine

Antiseptic compositions have received a lot of attention as efficient vaginal antiseptics. Even povidone iodine, which is present in metronidazole and cetrimide, has been proven to lower the likelihood of endometritis in women following delivery. Povidone iodine 1% has a good chance of becoming one of the most successful treatments for endometritis prophylaxis. Firms in the global povidone iodine market, on the other hand, are expanding the use of PVP-I to avoid secondary outcomes such as fever associated with endometritis and postoperative wound infection in women. These advantages are likely to support expansion of the global povidone iodine market in the years to come.

Povidone Iodine Market: Growth Drivers

  • In topical medication formulations, there is a rising need for a mix of anti-infectious treatment and healing-promoting moisturization. As a result, producers are ramping up manufacturing of povidone iodine liposome hydrogel, which may be used for both moist and antiseptic therapy.
  • The demand for povidone iodine infused dental floss has been fueled by an unacceptably increasing prevalence of periodontal disease amongst people all over the world. This is a common occurrence in Asian countries, which is why the sale of povidone iodine in the Asia Pacific region is projected to skyrocket in the years to come.

Request for covid19 Impact Analysis at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11612

Povidone Iodine Market: Key Competitors

  • Sumitomo Seika Chemicals Co. Ltd
  • Evonik Industries AG
  • Sanyo Chemical Industries
  • Nippon Shokubai Co., Ltd
  • KAO Corporation
  • LG Chem Ltd.

Povidone Iodine Market: Segmentation

Application

  • Skin Sterilization
  • Infection Prevention
  • Instrument Sterilization

E-commerce to Become Growth Back Bone of Chemical & Materials Market. Get a 360 Degree Peek into the Entire Chemical & Materials Industry @ https://www.transparencymarketresearch.com/chemical-market-reports-2.html

About Transparency Market Research

TMR has a track record to provide ace market research solutions that has earned us the trust of our clients for their business intelligence needs. Serving 13 industry verticals with a database of over 1,000 reports and 1 million + data points, our expanse to provide market research solutions is exceptional. We deep dive for a thorough understanding of the subject, gather precise information, and then analyze it to present solutions that are par excellence.

Contact
Mr Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,                                                                                                                
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com  
Blog: https://tmrblog.com/   
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/povidone-iodine-market.htm

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

Modal title

Also from this source

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Over the last year, several companies have announced new semiconductor fabrication sites, especially in the U.S., India, and Europe. These...

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

The market was valued at US$ 6.9 billion in 2022. The Silicon Metal Market Growth is estimated to reach US$ 10.7 billion by the end of 2031,...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Infection Control

Infection Control

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.